Research analysts at HC Wainwright lowered their Q1 2025 EPS estimates for Genelux in a report released on Monday, March 31st ...

Equities research analysts at HC Wainwright issued their Q3 2025 EPS estimates for shares of Defiance Silver in a research ...

H.C. Wainwright sees increased uncertainty for Sarepta’s Elevidys franchise after the European Medicines Agency placed a clinical hold on three drug trials. The clinical hold on ...

H.C. Wainwright lowered the firm’s price target on I-Mab (IMAB) to $7 from $8 and keeps a Buy rating on the shares. The company continues to ...

Shares of Sarepta Therapeutics, Inc. (SRPT) traded over 2% lower in afternoon trade on Friday after the company said it has ...

Sarepta (SRPT) and Roche (RHHBY) expect to submit data to address a clinical hold imposed on Elevidys, a gene therapy for ...

Analysts have set 12-month price targets for Orchestra BioMed Hldgs, revealing an average target of $14.5, a high estimate of ...

Two days after announcing his sweeping tariffs, U.S. President Donald Trump provided an update on a crucial trading partner – Vietnam. Trump said he had a “constructive call” with To Lam, General ...

Mark Jones makes 10 changes and Dwayne Peel just two for Sunday's European Challenge Cup follow-up to Scarlets URC win against Ospreys.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...